Format
Items per page
Sort by

Send to:

Choose Destination

Selected items

Items: 20

1.

Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management.

Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA, Maldonado-Garza H.

World J Gastroenterol. 2009 Jan 21;15(3):280-8. Review.

2.

Nonalcoholic fatty liver disease: from steatosis to cirrhosis.

Farrell GC, Larter CZ.

Hepatology. 2006 Feb;43(2 Suppl 1):S99-S112. Review.

PMID:
16447287
3.

Hyponatremia in cirrhosis and end-stage liver disease: treatment with the vasopressin V₂-receptor antagonist tolvaptan.

Gaglio P, Marfo K, Chiodo J 3rd.

Dig Dis Sci. 2012 Nov;57(11):2774-85. doi: 10.1007/s10620-012-2276-3. Epub 2012 Jun 26. Review.

4.

Does this patient with liver disease have cirrhosis?

Udell JA, Wang CS, Tinmouth J, FitzGerald JM, Ayas NT, Simel DL, Schulzer M, Mak E, Yoshida EM.

JAMA. 2012 Feb 22;307(8):832-42. doi: 10.1001/jama.2012.186.

PMID:
22357834
5.

Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis.

Villa E, Cammà C, Marietta M, Luongo M, Critelli R, Colopi S, Tata C, Zecchini R, Gitto S, Petta S, Lei B, Bernabucci V, Vukotic R, De Maria N, Schepis F, Karampatou A, Caporali C, Simoni L, Del Buono M, Zambotto B, Turola E, Fornaciari G, Schianchi S, Ferrari A, Valla D.

Gastroenterology. 2012 Nov;143(5):1253-60.e1-4. doi: 10.1053/j.gastro.2012.07.018. Epub 2012 Jul 20.

PMID:
22819864
6.

Is cirrhosis of the liver reversible?

Kumar M, Sarin SK.

Indian J Pediatr. 2007 Apr;74(4):393-9. Review.

PMID:
17476087
7.

Revision and update on clinical practice guideline for liver cirrhosis.

Suk KT, Baik SK, Yoon JH, Cheong JY, Paik YH, Lee CH, Kim YS, Lee JW, Kim DJ, Cho SW, Hwang SG, Sohn JH, Kim MY, Kim YB, Kim JG, Cho YK, Choi MS, Kim HJ, Lee HW, Kim SU, Kim JK, Choi JY, Jun DW, Tak WY, Lee BS, Jang BK, Chung WJ, Kim HS, Jang JY, Jeong SW, Kim SG, Kwon OS, Jung YK, Choe WH, Lee JS, Kim IH, Shim JJ, Cheon GJ, Bae SH, Seo YS, Choi DH, Jang SJ; Korean Association for the Study of the Liver.

Korean J Hepatol. 2012 Mar;18(1):1-21. doi: 10.3350/kjhep.2012.18.1.1. Epub 2012 Mar 22. No abstract available.

8.

Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy.

Peng CY, Chien RN, Liaw YF.

J Hepatol. 2012 Aug;57(2):442-50. doi: 10.1016/j.jhep.2012.02.033. Epub 2012 Apr 12. Review.

9.

[Classification of liver cirrhosis based on parenchymal echo patterns and its clinical usefulness for diagnosis of liver cirrhosis].

Kimura T, Ebara M, Ohto M, Kondo F.

Nihon Shokakibyo Gakkai Zasshi. 1989 Jul;86(7):1473-85. Japanese.

PMID:
2681891
10.

Liver cirrhosis.

Schuppan D, Afdhal NH.

Lancet. 2008 Mar 8;371(9615):838-51. doi: 10.1016/S0140-6736(08)60383-9. Review.

11.

The role of rifaximin in the primary prophylaxis of spontaneous bacterial peritonitis in patients with liver cirrhosis.

Hanouneh MA, Hanouneh IA, Hashash JG, Law R, Esfeh JM, Lopez R, Hazratjee N, Smith T, Zein NN.

J Clin Gastroenterol. 2012 Sep;46(8):709-15. doi: 10.1097/MCG.0b013e3182506dbb.

PMID:
22878533
12.

Diagnosis and therapy of ascites in liver cirrhosis.

Biecker E.

World J Gastroenterol. 2011 Mar 14;17(10):1237-48. doi: 10.3748/wjg.v17.i10.1237.

13.

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L.

N Engl J Med. 1996 Mar 14;334(11):693-9.

14.

Non-variceal gastrointestinal bleeding in patients with liver cirrhosis: a review.

Kalafateli M, Triantos CK, Nikolopoulou V, Burroughs A.

Dig Dis Sci. 2012 Nov;57(11):2743-54. doi: 10.1007/s10620-012-2229-x. Epub 2012 Jun 4. Review.

PMID:
22661272
15.

Milk thistle: effects on liver disease and cirrhosis and clinical adverse effects.

Mulrow C, Lawrence V, Jacobs B, Dennehy C, Sapp J, Ramirez G, Aguilar C, Montgomery K, Morbidoni L, Arterburn JM, Chiquette E, Harris M, Mullins D, Vickers A, Flora K.

Evid Rep Technol Assess (Summ). 2000;(21):1-3. No abstract available.

16.

Portal vein thrombosis, cirrhosis, and liver transplantation.

Francoz C, Valla D, Durand F.

J Hepatol. 2012 Jul;57(1):203-12. doi: 10.1016/j.jhep.2011.12.034. Epub 2012 Mar 21.

17.

Conversion of androgens to estrogens in cirrhosis of the liver.

Gordon GG, Olivo J, Rafil F, Southren AL.

J Clin Endocrinol Metab. 1975 Jun;40(6):1018-26.

PMID:
1133151
18.
19.

The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.

Bhala N, Angulo P, van der Poorten D, Lee E, Hui JM, Saracco G, Adams LA, Charatcharoenwitthaya P, Topping JH, Bugianesi E, Day CP, George J.

Hepatology. 2011 Oct;54(4):1208-16. doi: 10.1002/hep.24491. Epub 2011 Aug 9.

20.

Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients.

Zhang Z, Lin H, Shi M, Xu R, Fu J, Lv J, Chen L, Lv S, Li Y, Yu S, Geng H, Jin L, Lau GK, Wang FS.

J Gastroenterol Hepatol. 2012 Mar;27 Suppl 2:112-20. doi: 10.1111/j.1440-1746.2011.07024.x.

PMID:
22320928
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk